secwatch / observer
8-K filed Sep 29, 2025 23:59 UTC ticker AIXC CIK 0001460702
leadership confidence high sentiment neutral materiality 0.40

Qualigen Therapeutics appoints Kevin Chen as independent director effective Sept 26, 2025

AIxCrypto Holdings, Inc.

item 5.02item 9.01
Source: SEC EDGAR
accession 0001493152-25-015846

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.